Epiminder has reported the outcomes from the landmark UMPIRE (sub-scalp monitoring epileptic seizures) trial evaluating Minder, an implantable continuous electroencephalogram (EEG) monitoring system ...

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...

Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous electroencephalogram (EEG) monitoring ...

Researchers have created a hairlike device for long-term, non-invasive monitoring of the brain's electrical activity. The lightweight and flexible electrode attaches directly to the scalp and delivers ...